Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry: a Pilot Study
DOSI
1 other identifier
observational
78
1 country
1
Brief Summary
The brain is such a metabolically active organ that it consumes about 20% of oxygen burned every minute by an average adult even though it only contributes about 2% of the body weight. As a result, the brain produces a disproportionately high amount of CO2 every minute in comparison with the rest of the body.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 2, 2011
CompletedFirst Posted
Study publicly available on registry
December 1, 2011
CompletedStudy Start
First participant enrolled
December 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedNovember 1, 2022
October 1, 2022
Same day
August 2, 2011
October 28, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Brain blood flow
Optical Imaging assess of Brain blood flow during surgical procedure
6 hours
Study Arms (1)
Diagnostic tool
Diffuse Optical Spectroscopy Imaging Cerebrovascular Reactivity
Interventions
Diffuse Optical Spectroscopy Imaging Cerebrovascular Reactivity
Eligibility Criteria
Elective surgery
You may qualify if:
- Male or Female 20 years of age and older
- Female non-pregnant
- Subject scheduled for elective surgery under general anesthesia with intubation.
- Subject who is able to give informed consent.
You may not qualify if:
- Less than 20 years old of age
- Pregnant woman
- Subjects currently diagnosed with severe hypertension, myocardial ischemic disease, symptomatic valvular disease(s), symptomatic arrhythmia, uncompensated congestive heart failure, intracranial aneurysm.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCI Beckman Laser Institute
Irvine, California, 92612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Bruce Tromberg, PhD
Beckman Laser Institute
- PRINCIPAL INVESTIGATOR
Lingzhong Meng, M.D
Anesthesiology Perioperative Care
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lingzhong Meng, M.D.,Assistant Clinical Professor and Director of Neuroanesthesia
Study Record Dates
First Submitted
August 2, 2011
First Posted
December 1, 2011
Study Start
December 1, 2011
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
November 1, 2022
Record last verified: 2022-10